EPISODE · Mar 27, 2010 · 13 MIN
Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk?
from Clinical Conversations · host NEJM Group
We talk with three of the academic authors of a New England Journal of Medicine study that pooled data from a few studies in an attempt to examine the possible link between use of bisphosphonates and femoral-shaft fractures. Interview-related links: Physician’s First Watch coverage NEJM paper NEJM editorial FDA statement News-related links: Aspirin ineffective in preventing miscarriage BNP-guided therapy for heart failure Have kids at risk carry two epi-pens Rotarix contamination The post Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk? first appeared on Clinical Conversations.
Embed this episode
What this episode covers
We talk with three of the academic authors of a New England Journal of Medicine study that pooled data from a few studies in an attempt to examine the possible link between use of bisphosphonates and femoral-shaft fractures. Interview-related links: Physician’s First Watch coverage NEJM paper NEJM editorial FDA statement News-related links: Aspirin ineffective in preventing miscarriage BNP-guided […]
NOW PLAYING
Podcast 80: Bisphosphonates and atypical hip fractures — how large is the risk?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.